{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:25:08Z","timestamp":1791249908259,"version":"4.1.0"},"reference-count":228,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1378\/chest.08-0761","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T19:37:53Z","timestamp":1214249873000},"page":"844S-886S","source":"Crossref","is-referenced-by-count":586,"special_numbering":"S","title":["Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy"],"prefix":"10.1016","volume":"133","author":[{"given":"Shannon M.","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Pabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshanna","family":"Sofaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hirsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.08-0761_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1378\/chest.129.1.174","article-title":"Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Physicians Task Force","volume":"129","author":"Guyatt","year":"2006","journal-title":"Chest"},{"key":"10.1378\/chest.08-0761_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1646558","article-title":"Risks to the fetus of anticoagulant therapy during pregnancy","volume":"61","author":"Ginsberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0002-9343(80)90181-3","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy","volume":"68","author":"Hall","year":"1980","journal-title":"Am J Med"},{"key":"10.1378\/chest.08-0761_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0761_bib5","first-page":"229","article-title":"Intrauterine effects of coumarin derivatives","volume":"6","author":"Pauli","year":"1993","journal-title":"Dev Brain Dysfunct"},{"key":"10.1378\/chest.08-0761_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/hrt.55.1.101","article-title":"Cardiac valve prostheses, anticoagulation and pregnancy","volume":"55","author":"BenIsmail","year":"1986","journal-title":"Br Heart J"},{"key":"10.1378\/chest.08-0761_bib7","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/0002-9149(89)90008-8","article-title":"Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses","volume":"l63","author":"Sareli","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.08-0761_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0002-8703(92)90606-V","article-title":"Pregnancy in patients with prosthetic heart valves: the effect of anticoagulation on mother, fetus, and neonate","volume":"124","author":"Born","year":"1992","journal-title":"Am Heart J"},{"key":"10.1378\/chest.08-0761_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/14017438809106045","article-title":"Pregnancy in patients with prosthetic cardiac valves: a 10 years experience","volume":"22","author":"Pavankumar","year":"1988","journal-title":"Scand J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.08-0761_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0003-4975(10)60488-2","article-title":"Pregnancy and mechanical valves prostheses: a high risk situation for the mother and the fetus","volume":"36","author":"Larrea","year":"1983","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0761_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1010-7940(02)00302-0","article-title":"Pregnancy and mechanical heart valves replacement: dilemma of anticoagulation","volume":"22","author":"Al-Lawati","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1378\/chest.08-0761_bib12","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM198611273152205","article-title":"Risks of anticoagulant therapy in pregnant women with artificial heart valves","volume":"315","author":"IturbeAlessio","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1160\/TH06-02-0108","article-title":"Vitamin K antagonists and pregnancy outcome: a multi-centre prospective study","volume":"95","author":"Schaefer","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-0037-1615641","article-title":"Coumarins during pregnancy: long term effects on growth and development in school age children","volume":"85","author":"Wesseling","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1542\/peds.107.1.123","article-title":"exposure to coumarins and cognition at 8 to 14 years old","volume":"107","author":"vanDriel","year":"2001","journal-title":"Pediatrics"},{"key":"10.1378\/chest.08-0761_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/bmj.1.5691.270","article-title":"Clinical experience with anticoagulant therapy during pregnancy","volume":"1","author":"Hirsh","year":"1970","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0735-1097(99)00044-3","article-title":"Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves","volume":"33","author":"Vitale","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.08-0761_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib19","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/archinte.1989.00390100059015","article-title":"Heparin therapy during pregnancy: risks to the fetus and mother","volume":"149","author":"Ginsberg","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0761_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1651102","article-title":"Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy","volume":"57","author":"Forestier","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib22","first-page":"1134","article-title":"Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies","volume":"108","author":"Lepercq","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib23","first-page":"1319","article-title":"Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review","volume":"101","author":"Coomarasamy","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0049-3848(86)90002-2","article-title":"Placental transfer of Org 10172, a low-molecular-weight heparinoid in the awake late-pregnant guinea pig","volume":"44","author":"Peeters","year":"1986","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0038-1642546","article-title":"Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular-weight heparinoid [letter]","volume":"55","author":"Henny","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90178-Q","article-title":"Pregnancy-complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172)","volume":"71","author":"Greinacher","year":"1993","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1160\/TH04-06-0345","article-title":"Treatment of 51 pregnancies with danaparoid because of heparin intolerance","volume":"93","author":"Lindhoff-Last","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2002-35284","article-title":"Heparin-induced thrombocytopenia: alternative anticoagulation in pregnancy and lactation","volume":"28","author":"Lindhoff-Last","year":"2002","journal-title":"Semin Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib30","first-page":"202","article-title":"Pharmacological survey of recombinant hirudin","volume":"43","author":"Markwardt","year":"1988","journal-title":"Pharmazie"},{"key":"10.1378\/chest.08-0761_bib31","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1538-7836.2004.00883.x","article-title":"Treatment of heparin induced thrombocytopenia and thrombosis during first trimester of pregnancy [letter]","volume":"2","author":"Mehta","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib32","first-page":"19","article-title":"Heparin-induced thrombocytopenia occurring in the first trimester of pregnancy: successful treatment with lepirudin; a case-report [letter]","volume":"91","author":"Furlan","year":"2006","journal-title":"Haematologica"},{"key":"10.1378\/chest.08-0761_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1055\/s-0037-1613092","article-title":"Absence of placental transfer of pentasaccharide (fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro","volume":"87","author":"Lagrange","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib34","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1056\/NEJM200404293501825","article-title":"Minor transplacental passage of fondaparinux in vivo [letter]","volume":"350","author":"Dempfle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.thromres.2006.03.008","article-title":"Treatment of a woman with lupus and thromboembolism and cutaneous intolerance of heparins using fondaparinux during pregnancy [letter]","volume":"119","author":"Harenberg","year":"2007","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib36","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1182\/blood-2006-03-009548","article-title":"Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy","volume":"108","author":"Mazzolai","year":"2006","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1378\/chest.08-0761_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/imj.1970.19.s1.17","article-title":"Distribution studies and placental transfer of 131 I streptokinase","volume":"19","author":"Pfeifer","year":"1970","journal-title":"Australas Ann Med"},{"key":"10.1378\/chest.08-0761_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11239-006-5709-z","article-title":"Thrombolytic therapy in pregnancy","volume":"21","author":"Leonhardt","year":"2006","journal-title":"J Thromb Thrombolysis"},{"key":"10.1378\/chest.08-0761_bib39","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/archinte.162.11.1221","article-title":"Massive pulmonary embolism during pregnancy treated with recombinant tissue plasminogen activator: a case report and review of treatment options","volume":"162","author":"Ahearn","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0761_bib40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.siny.2004.09.016","article-title":"Drugs and chemicals in human milk","volume":"10","author":"Berlin","year":"2005","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1378\/chest.08-0761_bib41","first-page":"938","article-title":"Coumarin derivatives and breast-feeding","volume":"95","author":"Clark","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib42","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/bmj.1.6076.1564","article-title":"May mothers given warfarin breast-feed their infants?","volume":"1","author":"Orme","year":"1977","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0022-3476(83)80378-3","article-title":"Is warfarin sodium contraindicated in the lactating mother?","volume":"103","author":"McKenna","year":"1983","journal-title":"J Pediatr"},{"key":"10.1378\/chest.08-0761_bib44","series-title":"The pharmacologic basis of therapeutics","first-page":"1347","article-title":"Anticoagulant, antithrombotic and thrombolytic drugs","author":"O'Reilly","year":"1980"},{"key":"10.1378\/chest.08-0761_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.0306-5251.2001.01517.x","article-title":"Excretion of low-molecular-weight heparin in human milk","volume":"52","author":"Richter","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.08-0761_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(00)82018-8","article-title":"Hirudin treatment in a breastfeeding woman [letter]","volume":"355","author":"Lindhoff-Last","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib47","first-page":"92","article-title":"The aPTT response of pregnant plasma to unfractionated heparin","volume":"87","author":"Chunilal","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thromboembolism","volume":"306","author":"Hull","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib49","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198212303072704","article-title":"Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis","volume":"307","author":"Hull","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0038-1647659","article-title":"Subcutaneous heparin therapy during pregnancy: a need for concern at the time of delivery","volume":"65","author":"Anderson","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib51","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","article-title":"Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin","volume":"332","author":"Warkentin","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM198807213190304","article-title":"Incidentally detected thrombocytopenia in healthy mothers and their infants","volume":"319","author":"Burrow","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-123-1-199507010-00001","article-title":"Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial","volume":"123","author":"deValek","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0761_bib54","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1055\/s-0038-1649626","article-title":"Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172)","volume":"70","author":"Magnani","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib55","first-page":"254","article-title":"The effects of long-term heparin therapy during pregnancy on bone density","volume":"70","author":"Douketis","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib56","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0002-9378(93)90378-V","article-title":"Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin","volume":"168","author":"Dahlman","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1055\/s-0038-1647302","article-title":"Heparin effect on bone density","volume":"64","author":"Ginsberg","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1471-0528.1990.tb01785.x","article-title":"Osteopenia in pregnancy during long-term heparin treatment: a radiological study post-partum","volume":"97","author":"Dahlman","year":"1990","journal-title":"Br J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0038-1642376","article-title":"Comparison of subcutaneous unfractionated heparin with low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin","volume":"71","author":"Monreal","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0037-1612970","article-title":"Postpartum bone mineral density in women treated with thromboprophylaxis with unfractionated heparin or LMW heparin","volume":"87","author":"Pettila","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib61","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V88.4.1314.bloodjournal8841314","article-title":"Histomorphometric analysis of the effect of standard heparin on trabecular bone in vivo","volume":"88","author":"Muir","year":"1996","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib62","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood.V89.9.3236","article-title":"A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats","volume":"89","author":"Muir","year":"1997","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib63","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood.V93.4.1231","article-title":"A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin-treatment in rats","volume":"93","author":"Shaughnessy","year":"1999","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib64","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-130-10-199905180-00003","article-title":"Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute venous thrombosis: a meta-analysis of randomized, controlled trials","volume":"130","author":"Gould","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0761_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized controlled trials","volume":"140","author":"Quinlan","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0761_bib66","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1161\/CIRCULATIONAHA.105.573550","article-title":"Unfractionated heparin and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation myocardial infarction: a meta-analysis of the randomized trials","volume":"112","author":"Eikelboom","year":"2005","journal-title":"Circulation"},{"key":"10.1378\/chest.08-0761_bib67","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparin","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib71","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/humrep\/deh115","article-title":"Prospective observational study of bone mineral density during pregnancy: low molecular-weight heparin versus control","volume":"19","author":"Carlin","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1378\/chest.08-0761_bib72","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/003693309604100305","article-title":"Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience","volume":"41","author":"Macklon","year":"1996","journal-title":"Scott Med J"},{"key":"10.1378\/chest.08-0761_bib74","first-page":"730","article-title":"Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib75","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/mob.2002.119177","article-title":"Pulmonary embolism and stroke in relation to pregnancy: how can high-risk women be identified?","volume":"186","author":"Ros","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.thromres.2004.03.008","article-title":"Deep vein thrombosis after elective cesarean section","volume":"113","author":"Jacobsen","year":"2004","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib77","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jclinepi.2004.02.003","article-title":"ICD-9-CM codes poorly identified venous thromboembolism during pregnancy","volume":"57","author":"White","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1378\/chest.08-0761_bib78","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ajog.2005.07.044","article-title":"Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section","volume":"194","author":"Rodger","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 126","key":"10.1378\/chest.08-0761_bib79","doi-asserted-by":"crossref","first-page":"338S","DOI":"10.1378\/chest.126.3_suppl.338S","article-title":"Prevention of venous thromboembolism","author":"Geerts","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-0761_bib80","series-title":"Report of the RCOG working party on prophylaxis against thromboembolism in gynaecology and obstetrics","author":"Royal College of Obstetricians and Gynaecologists","year":"1995"},{"key":"10.1378\/chest.08-0761_bib82","first-page":"CD001689","article-title":"Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period","author":"Gates","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.08-0761_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2005-872428","article-title":"Changes in plasma coagulation markers with prophylactic treatment of low molecular weight heparin after caesarean section","volume":"31","author":"Hirota","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"10.1378\/chest.08-0761_bib84","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1055\/s-0037-1616738","article-title":"Thromboprophylaxis following caesarean section: a comparison of the antithrombotic properties of three low molecular weight heparins; dalteparin, enoxaparin, and tinzaparin","volume":"86","author":"Ellison","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib85","first-page":"835","article-title":"A randomized double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study","volume":"108","author":"Burrows","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib86","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ajog.2004.03.039","article-title":"on behalf of the Thromboprophylaxis in Pregnancy Advisory Group. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin","volume":"191","author":"Gates","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib87","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/bmj.296.6635.1505-a","article-title":"Effect of low dose heparin on blood loss at caesarean section","volume":"296","author":"Hill","year":"1988","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1471-0528.1998.tb10212.x","article-title":"Pueperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin","volume":"105","author":"Gibson","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib89","first-page":"10","article-title":"Perioperative thrombosis prophylaxis at the time of caesarean section: results of a randomized prospective comparative study; with 6% hydroxyethyl starch 0.62 and low-dose heparin [in German]","volume":"195","author":"Heilmann","year":"1991","journal-title":"Z Geburtshilfe Pernatol"},{"key":"10.1378\/chest.08-0761_bib90","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.AOG.0000178792.51401.3a","article-title":"Thromboprophylaxis after cesarean delivery: a decision analysis","volume":"106","author":"Qui\u00f1ones","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib91","doi-asserted-by":"crossref","first-page":"311S","DOI":"10.1378\/chest.126.3_suppl.311S","article-title":"Heparin-induced thrombocytopenia: recognition, treatment, and prevention","volume":"126","author":"Warkentin","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.08-0761_bib92","first-page":"1","article-title":"Pregnancy-related mortality surveillance: United States, 1991\u20131999","volume":"52","author":"Chang","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1378\/chest.08-0761_bib93","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2141.2000.01877.x","article-title":"Prevention of the post-thrombotic syndrome in young women with previous venous thromboembolism","volume":"108","author":"McColl","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.08-0761_bib94","first-page":"595","article-title":"Thrombotic risk during pregnancy: a population study","volume":"94","author":"Lindqvist","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib95","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/j.1600-0412.1998.770207.x","article-title":"The cumulative incidence of venous thromboembolism during pregnancy and puerperium: an 11 year Danish population-based study of 63,300 pregnancies","volume":"77","author":"Andersen","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1378\/chest.08-0761_bib96","first-page":"56","article-title":"Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database","volume":"108","author":"Simpson","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib97","first-page":"254","article-title":"Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and leg of presentation","volume":"54","author":"Ray","year":"1999","journal-title":"Obstet Gynecol Surv"},{"key":"10.1378\/chest.08-0761_bib98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0038-1648837","article-title":"Low-molecular-weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis","volume":"72","author":"Lopaciuk","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib99","first-page":"CD002001","article-title":"Vitamin K antagonists or low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism","author":"van der Heijden","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.08-0761_bib100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib101","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0049-3848(99)00228-5","article-title":"Pharmacokinetic profile of a low-moelcular weight heparin (Reviparin) in pregnant patients: a prospective cohort study","volume":"98","author":"Crowther","year":"2000","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib102","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajog.2004.05.050","article-title":"A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation","volume":"191","author":"Barbour","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1471-0528.2003.02182.x","article-title":"Low molecular weight heparin (dalteparin) for treatment of venous thromboembolism in pregnancy","volume":"110","author":"Jacobsen","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib104","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1471-0528.2002.01525.x","article-title":"Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: case series","volume":"109","author":"Rodie","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib105","first-page":"139","article-title":"Partial reversal of low molecular-weight heparin (PK 101699) anti-Xa activity by protamine sulfate: in vitro and in vivo study during cardiac surgery with extracorporeal circulation","volume":"16","author":"Massonnet-Castel","year":"1986","journal-title":"Haemostasis"},{"key":"10.1378\/chest.08-0761_bib106","series-title":"Deep venous thrombosis: hematology; American Society of Hematology Education Program","first-page":"439","article-title":"Risk factors for recurrent venous thromboembolism and their implications for treatment","author":"Kearon","year":"2004"},{"key":"10.1378\/chest.08-0761_bib107","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib108","first-page":"264","article-title":"Low risk of recurrent thromboembolism in pregnancy [letter]","volume":"38","author":"DeSwiet","year":"1987","journal-title":"Br J Hosp Med"},{"key":"10.1378\/chest.08-0761_bib109","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1471-0528.1983.tb06458.x","article-title":"The risk of antenatal subcutaneous heparin prophylaxis: a controlled trial","volume":"90","author":"Howell","year":"1983","journal-title":"Br J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/bmj.1.5901.215","article-title":"Recurrent venous thromboembolic disease and use of oral contraceptives","volume":"1","author":"Badaracco","year":"1974","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib111","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(89)90095-1","article-title":"Recurrent thromboembolism in pregnancy and puerperium: is there a need for thromboprophylaxis?","volume":"160","author":"Tengborn","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib112","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"for the Recurrence Of Clot In This Pregnancy (ROCIT) Study Group: safety of withholding antepartum heparin in women with a previous episode of venous thromboembolism","volume":"343","author":"Brill-Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib113","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated venous thromboembolism in women with a history of venous thromboembolism","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib114","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0049-3848(99)00110-3","article-title":"Thromboprophylaxis with low-molecular-weight heparin \u201cdalteparin\u201d in pregnancy","volume":"96","author":"Pettila","year":"1999","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib116","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib117","first-page":"1","article-title":"Thromboprophylaxis with low molecular mass heparin, \u201cFragmin\u201d (dalteparin), during pregnancy: longitudinal safety study","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1378\/chest.08-0761_bib118","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1378\/chest.08-0761_bib119","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000040922","article-title":"Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin","volume":"101","author":"Brennand","year":"1999","journal-title":"Acta Haematol"},{"key":"10.1378\/chest.08-0761_bib120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","article-title":"Low molecular weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies","volume":"87","author":"Dulitzki","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib121","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","article-title":"Changes in the pharmacokinetics of the low molecular weight heparin enoxaparin sodium during pregnancy","volume":"181","author":"Casele","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib122","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-0528.2000.tb11110.x","article-title":"Antifactor Xa profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin for prevention and treatment of thromboembolism in pregnancy","volume":"107","author":"Ellison","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib123","first-page":"138","article-title":"Inter-assay and instrument variability of anti-Xa results","volume":"85","author":"Kovacs","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib124","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1055\/s-0037-1614377","article-title":"Anti-Xa monitoring during treatment with low-molecular-weight heparin or danaparoid: inter-assay variability","volume":"82","author":"Kitchen","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib125","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJM198805053181805","article-title":"Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin","volume":"318","author":"Collins","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib126","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-2006-955459","article-title":"Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia","volume":"32","author":"DeStefano","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1378\/chest.08-0761_bib127","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(98)10265-9","article-title":"Thrombosis in pregnancy: maternal and fetal issues","volume":"353","author":"Greer","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"for The Thrombosis Risk and Economic Assessment of Thrombophilia Screening (Treats) Study: thrombophilia in pregnancy; a systematic review","volume":"132","author":"Robertson","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.08-0761_bib129","first-page":"14","article-title":"Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis","volume":"95","author":"Biron-Andreani","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.AOG.0000173986.32528.ca","article-title":"For the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus","volume":"106","author":"Dizon-Townson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib131","first-page":"360","article-title":"Counselling women with factor V Leiden homozygosity: use absolute instead of relative risks","volume":"87","author":"Middledorp","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib132","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2141.2001.02766.x","article-title":"The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden","volume":"113","author":"Middledorp","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1378\/chest.08-0761_bib133","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1055\/s-0037-1616134","article-title":"Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia","volume":"86","author":"Martinelli","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.thj.6200005","article-title":"Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden","volume":"1","author":"Pabinger","year":"2000","journal-title":"Hematol J"},{"key":"10.1378\/chest.08-0761_bib135","first-page":"1305","article-title":"Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women","volume":"86","author":"Tormene","year":"2001","journal-title":"Haematologica"},{"key":"10.1378\/chest.08-0761_bib136","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1538-7836.2004.0584h.x","article-title":"are there any predictive factors?","volume":"2","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib137","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0761_bib138","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM200002103420602","article-title":"Prothrombin and factor V mutations in women with thrombosis during pregnancy and the puerperium","volume":"342","author":"Gerhardt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib139","first-page":"1183","article-title":"Risk factors for pregnancy associated venous thromboembolism","volume":"8","author":"McColl","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1646452","article-title":"The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study","volume":"66","author":"Long","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib141","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk for deep-vein thrombosis","volume":"334","author":"DenHeijer","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib142","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM200002103420610","article-title":"The challenge of thrombophilia in maternal-fetal medicine","volume":"342","author":"Greer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib143","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00003081-199409000-00016","article-title":"Recurrent miscarriage epidemiologic factors, definitions, and incidence","volume":"37","author":"Hatasaka","year":"1994","journal-title":"Clin Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib144","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2003-08-2744","article-title":"Clinical management of thrombophilia-related placental vascular complications","volume":"103","author":"Brenner","year":"2004","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00095-1","article-title":"Thrombophilia: implications for pregnancy outcome","volume":"109","author":"Greer","year":"2003","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib146","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.96.14.8138","article-title":"Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation","volume":"96","author":"Erlich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.08-0761_bib147","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","article-title":"Action of anticardiolin and antibodies to \u03b22-glycoprotein\u2013I on trophoblast proliferation as a mechanism for fetal death","volume":"352","author":"Chamley","year":"1998","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib148","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1073\/pnas.90.14.6464","article-title":"Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation","volume":"90","author":"Sthoeger","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.08-0761_bib149","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM199707173370303","article-title":"Pregnancy loss in the antiphospholipid antibody syndrome: a possible thrombogenic mechanism","volume":"337","author":"Rand","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib151","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI3011","article-title":"Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice","volume":"102","author":"Jalbert","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.08-0761_bib152","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1073\/pnas.92.3.850","article-title":"Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system","volume":"92","author":"Healy","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1378\/chest.08-0761_bib153","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood.V80.4.975.975","article-title":"Relationship of antiphosopholipid antibodies to pregnancy loss in patients with systemic lupus erythematosis: a cross-sectional study","volume":"80","author":"Ginsberg","year":"1992","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib154","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib155","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","article-title":"High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1378\/chest.08-0761_bib156","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.08-0761_bib157","first-page":"541","article-title":"The association of antiphospholipid antibodies with severe preeclampsia","volume":"73","author":"Branch","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib158","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0029-7844(95)00247-O","article-title":"Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy","volume":"86","author":"Yasuda","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib159","first-page":"1108","article-title":"The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction","volume":"78","author":"Polzin","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0002-9378(89)90522-X","article-title":"The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population","volume":"161","author":"Lockwood","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib161","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to anticardiolipin as a predictor of fetal distress or death in pregnant women with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib162","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9378(11)90692-9","article-title":"Recurrent adverse pregnancy outcome and antiphospholipid antibodies","volume":"163","author":"Reece","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib163","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9378(91)90222-D","article-title":"The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation","volume":"165","author":"Milliez","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib164","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0002-9378(91)90695-N","article-title":"The relationship between autoantibodies and intrauterine growth retardation in hypertensive disorders of pregnancy","volume":"164","author":"El-Roeiy","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0897.1996.tb00143.x","article-title":"Antiphospholipid antibodies in patients with preeclampsia","volume":"36","author":"Allen","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1378\/chest.08-0761_bib166","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","article-title":"Incidence of the factor V Leiden mutation, coagulation inhibitor deficiencies and elevated antiphospholipid antibodies in patients with preeclampsia or HELLP syndrome [letter]","volume":"100","author":"von Tempelhoff","year":"2000","journal-title":"Thromb Res"},{"key":"10.1378\/chest.08-0761_bib167","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/00016349209007966","article-title":"Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome","volume":"71","author":"Sletnes","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1378\/chest.08-0761_bib168","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-120-6-199403150-00004","article-title":"Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study","volume":"120","author":"Lynch","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.08-0761_bib169","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0002-9378(12)90741-3","article-title":"Should anticardiolipin tests be performed in otherwise healthy pregnant women?","volume":"165","author":"Harris","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib170","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1067\/mob.2001.113846","article-title":"For the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.Antiphospholipid antibodies in women at risk for preeclampsia","volume":"184","author":"Branch","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib171","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9378(11)91619-6","article-title":"A prospective, controlled multicentre study on the obstetric risks of pregnant women with antiphospholipid antibodies","volume":"167","author":"Out","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib172","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(89)92069-2","article-title":"Clinical relevance of specific IgG antibodies to cardiolipin","volume":"8669","author":"Faux","year":"1989","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib173","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1471-0528.1991.tb10382.x","article-title":"Pre-eclampsia and antiphospholipid antibody","volume":"98","author":"Taylor","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib174","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1471-0528.1987.tb03162.x","article-title":"Anticardiolipin antibodies and preeclampsia","volume":"94","author":"Scott","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib175","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib176","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH03-10-0637","article-title":"The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis","volume":"91","author":"Dudding","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib177","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archinte.164.5.558","article-title":"Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis","volume":"164","author":"Kovalevsky","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.08-0761_bib178","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2005.01581.x","article-title":"Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control \u2018NOHA first' study","volume":"3","author":"Lissalde-Lavigne","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib179","first-page":"684","article-title":"Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia","volume":"99","author":"Many","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsgi.2003.07.008","article-title":"Genetic polymorphisms associated with thrombophilia and vascular disease in women with unexplained late intrauterine fetal death: a multicenter study","volume":"11","author":"Hefler","year":"2004","journal-title":"J Soc Gynecol Invest"},{"key":"10.1378\/chest.08-0761_bib181","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","article-title":"Underlying disorders associated with severe early-onset preeclampsia","volume":"173","author":"Dekker","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib182","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","article-title":"Preeclampsia and its interaction with common variants in thrombophilia genes","volume":"2","author":"DeMaat","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib183","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.HYP.0000188979.74172.4d","article-title":"Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study","volume":"46","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1378\/chest.08-0761_bib184","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib185","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib186","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib187","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1378\/chest.08-0761_bib188","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1378\/chest.08-0761_bib189","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0002-9378(97)70409-5","article-title":"Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial","volume":"176","author":"Cowchock","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib190","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib191","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/humrep\/12.7.1567","article-title":"Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production","volume":"12","author":"Tulppala","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1378\/chest.08-0761_bib192","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.08-0761_bib193","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200209000-00004","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib194","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1378\/chest.08-0761_bib195","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1378\/chest.08-0761_bib196","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1378\/chest.08-0761_bib197","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0037-1614594","article-title":"Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent: the Nimes Obstetricians and Haematologists Study 5 (NOHA5)","volume":"81","author":"Gris","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib198","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib199","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1378\/chest.08-0761_bib201","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","article-title":"Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study","volume":"84","author":"Brenner","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1378\/chest.08-0761_bib202","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib203","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1538-7836.2005.01286.x","article-title":"The use of LMWH in pregnancies at risk: new evidence or perception?","volume":"3","author":"Walker","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1538-7836.2005.01155.x","article-title":"Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?","volume":"3","author":"Lindqvist","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib205","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1378\/chest.08-0761_bib206","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2004.08.001","article-title":"Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known and unknown aetiology","volume":"120","author":"Tzafettas","year":"2005","journal-title":"Eur J Obstet Gynaecol Reprod Biol"},{"key":"10.1378\/chest.08-0761_bib207","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1471-0528.1981.tb01268.x","article-title":"An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation","volume":"88","author":"Sheppard","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib208","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1210\/jc.2002-021942","article-title":"Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia","volume":"88","author":"Koga","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1378\/chest.08-0761_bib209","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(80)92746-4","article-title":"Maternal vascular prostacyclin activity in pre-eclapsia","volume":"2","author":"Bussolino","year":"1980","journal-title":"Lancet"},{"key":"10.1378\/chest.08-0761_bib210","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10641959909009611","article-title":"Mechanisms of endothelium-dependent relation in myometrial resistance vessels and their alteration in preeclampsia","volume":"18","author":"Ashworth","year":"1999","journal-title":"Hypertens Pregnancy"},{"key":"10.1378\/chest.08-0761_bib211","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1016248","article-title":"Endothelial dysfunction in preeclampsia","volume":"16","author":"Roberts","year":"1998","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1378\/chest.08-0761_bib212","series-title":"Handbook of hypertension: hypertension in pregnancy","first-page":"163","article-title":"Platelets and coagulation abnormalities in pre-eclampsia","author":"Greer","year":"1999"},{"key":"10.1378\/chest.08-0761_bib213","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","article-title":"Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies","volume":"330","author":"Duckitt","year":"2005","journal-title":"BMJ"},{"key":"10.1378\/chest.08-0761_bib214","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1067\/mob.2002.120280","article-title":"Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas","volume":"186","author":"Hnat","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib215","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2003","journal-title":"Cochrane Database Systematic Rev"},{"key":"10.1378\/chest.08-0761_bib216","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/molehr\/gal026","article-title":"Heparin prevents programmed cell death in human trophoblast","volume":"12","author":"Hills","year":"2006","journal-title":"Mol Hum Reprod"},{"key":"10.1378\/chest.08-0761_bib217","first-page":"83","article-title":"Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?","volume":"62","author":"Kalk","year":"2004","journal-title":"Neth J Med"},{"key":"10.1378\/chest.08-0761_bib218","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertens"},{"key":"10.1378\/chest.08-0761_bib219","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/021849230501300107","article-title":"Anticoagulation in patients with mechanical valves during pregnancy","volume":"13","author":"Geelani","year":"2005","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1378\/chest.08-0761_bib220","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ajog.2004.05.064","article-title":"Pregnancy outcome in women with prosthetic heart valves","volume":"191","author":"Nassar","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib221","first-page":"101","article-title":"Is there a safe anticoagulation protocol for pregnant women with prosthetic valves?","volume":"25","author":"Arnaout","year":"1998","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1378\/chest.08-0761_bib222","first-page":"6288","article-title":"Low molecular-weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valves replacement [letter]","volume":"76","author":"Lee","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib223","first-page":"327","article-title":"Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin","volume":"108","author":"Roberts","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1378\/chest.08-0761_bib224","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1010-7940(01)01154-X","article-title":"Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative","volume":"21","author":"Leyh","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1378\/chest.08-0761_bib225","first-page":"745","article-title":"Failure of low molecular weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and review of options for anticoagulation","volume":"11","author":"Mahesh","year":"2002","journal-title":"J Heart Valve Dis"},{"key":"10.1378\/chest.08-0761_bib226","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(99)00874-7","article-title":"Low-molecular-weight heparin for prosthetic heart valves: treatment failure","volume":"69","author":"Lev-Ran","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.08-0761_bib227","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/clc.4950250704","article-title":"Low-molecular-weight heparin for the treatment of patients with mechanical heart valves","volume":"25","author":"Shapira","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1378\/chest.08-0761_bib228","series-title":"Lovenox Injection (package insert)","year":"2004"},{"key":"10.1378\/chest.08-0761_bib229","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1160\/TH04-06-0337","article-title":"Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy","volume":"92","author":"Oran","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.08-0761_bib230","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","article-title":"A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement","volume":"329","author":"Turpie","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369208601324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T11:21:48Z","timestamp":1588764108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369208601324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":228,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0012369208601324"],"URL":"https:\/\/doi.org\/10.1378\/chest.08-0761","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116768.573858","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}